Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

Susan A. Charman, Sarah Arbe-Barnes, Ian C. Bathurst, Reto Brund, Michael Campbell, William N. Charman, Francis C.K. Chiu, Jacques Chollet, J. Carl Craft, Darren J. Creek, Yuxiang Don, Hugues Matile, Melanie Maurer, Julia Morizzi, Tien Nguyen, Petros Papastogiannidis, Christian Scheurer, David M. Shackleford, Kamaraj Sriraghavan, Lukas StingelinYuanqing Tang, Heinrich Urwyler, Xiaofang Wang, Karen L. White, Sergio Wittlin, Lin Zhou, Jonathan L. Vennerstrom

Research output: Contribution to journalArticlepeer-review

321 Scopus citations

Fingerprint

Dive into the research topics of 'Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria'. Together they form a unique fingerprint.

Medicine & Life Sciences